KaalundS., HogsaaB., GrevyC., OxlundH.Reduced strength of skin in Ehlers-Danlos syndrome type III.Scand J Rheumat Dis1990; 19: 67–70
2.
Arendt-NielsenL., KaalundS., BjerringP., HogsaaB.Insufficient effect of local analgesics in Ehlers Danlos type III patients (connective tissue disorder).Acta Anaesth Scand1990; 34: 358–61
3.
GrahameR.Joint hypermobility and genetic collagen disorders: are they related?Arch Dis Childh1999; 80: 188–91
4.
ZweersM.C., KucharekovaM., SchalkwijkJ.Tenascin-X: a candidate gene for benign joint hypermobility syndrome and hypermobility type Ehlers-Danlos syndrome?Ann Rheumat Dis (in press)
5.
BuckinghamR.B., BraunT., HarinsteinD.A.. Temporomandibular joint dysfunction syndrome: a close association with systemic joint laxity (the hypermobile joint syndrome).Oral Surg Oral Med Oral Pathol1991; 72: 514–19
6.
GrahameR., HakimA.J.High prevalence of joint hypermobility syndrome in clinic referrals to a north London community hospital.Rheumatology2004; 43(suppl 2): 91
7.
HakimA.J., GrahameR.A simple questionnaire to detect hypermobility: an adjunct to the assessment of patients with diffuse musculoskeletal pain.Int J Clin Practice2003; 57: 163–6
8.
GrahameR., BirdH.A., ChildA.. The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS).J Rheumatol2000; 27: 1777–9
9.
BeightonP.H., SolomonL., SoskolneC.L.Articular mobility in an African population.Ann Rheumat Dis1973; 32: 413–17